PERRYMAN LAURA TYLER has a total of 14 patent applications. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets medical technology, electrical machinery and energy and computer technology are SALVIA BIOELECTRONICS B V, NUXCEL INC and STIMAIRE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 5 | |
#3 | China | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Electrical machinery and energy | |
#3 | Computer technology | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Electrotherapy | |
#2 | Diagnosis and surgery | |
#3 | Circuits for supplying electric power | |
#4 | Healthcare informatics | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Perryman Laura Tyler | 14 |
#2 | Andresen Chad | 9 |
#3 | Larson Patrick | 4 |
#4 | Andresen Chad David | 3 |
#5 | Lebaron Richard | 2 |
#6 | Bakkaloglu Bertan | 1 |
#7 | Greene Graham Patrick | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016209948A1 | An earpiece assembly to interact with implantable neural stimulators | |
WO2014153219A1 | Devices and methods for treating urological disorders | |
WO2014153228A1 | Miniature implantable device and methods | |
US2016015988A1 | Treating inflammation, chronic pain and other disorders with neuromodulation | |
WO2014153223A1 | Treating inflammation, chronic pain and other disorders with neuromodulation | |
US2012303098A1 | Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostasis and insulin production |